Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    In the log, Revision: v3.5.0 was added and Revision: v3.4.3 was crossed out.
    Difference
    0.0%
    Check dated 2026-03-19T00:01:33.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:09:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added as the latest version in the study's history, replacing the earlier v3.4.1. The notice about government funding and operating status was removed from the page.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:53.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page shows two minor administrative updates: a site-wide notice regarding government funding and a new revision tag (v3.4.1) that supersedes v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:56:02.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The history page adds a glossary display option and color-coded highlights for additions and deletions, and updates the revision label from v3.3.4 to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T04:28:33.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:16:51.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.